Article

Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

2024-12-10

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and objective</h4> Device-aided therapies (DATs) are treatments indicated for people with Parkinsońs disease (PwP) with clinical fluctuations that are not optimally controlled with conventional medication. New DATs have recently emerged such as levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) and subcutaneous infusion of foslevodopa/foscarbidopa (fLD/fCD). It is necess...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 816561c7-32d2-5d44-b633-c6d4a2c77d9e
DOI: 10.1101/2024.12.07.24318643

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol StudyDOI 10.1101/2024.12.07.24318643Read

AccessPD - a ‘next generation’ registry to accelerate Parkinson’s disease researchSemantic proximity Read

Next-Generation Cranial Nerve Stimulation and Neuromodulation Techniques: Potential and Clinical Applications in Parkinson’s Disease TreatmentSemantic proximity Read

Transporter Single Photon Emission Computed Tomography (DaT-SPECT) use in The Diagnosis and Clinical Management of Parkinsonism: An Eight-Year Retrospective StudySemantic proximity Read

Change in deep brain stimulation effect in Parkinson’s disease after replacement with a new generation neurostimulatorSemantic proximity Read

Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation.Semantic proximity Read

Physical therapy in patients with Parkinson’s disease treated with Deep Brain Stimulation: a Delphi panel studySemantic proximity Read

Predicting Parkinson’s Disease Medication Regimen Using Sensor TechnologySemantic proximity Read

Istradefylline Safety Profiles: Examination of Individual Case Safety Reports in the FDA Adverse Event Reporting System (FAERS) DatabaseSemantic proximity Read

Real-World Experience of Deep Brain Stimulation Surgery in a Developing Southeast Asian CountrySemantic proximity Read

Acute effects of Adaptive Deep Brain Stimulation in Parkinson’s diseaseSemantic proximity Read

Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations.Semantic proximity Read

Using a Smartwatch and Smartphone to Assess Early Parkinson’s Disease in the WATCH-PD Study – 12-month resultsSemantic proximity Read